Carbonyldiimidazole (CDI) was inventively used as an accelerator for the curing reaction of diglycidyl ether of bisphenol A (DGEBA) with dicyandiamide (DICY) and a high acceleration more effective than imidazole in double usage was observed. This result implies the accelerating role of CDI in the curing process is complex and involved not only the release of imidazole. To detail the accelerating mechanism of CDI, a series of curing reactions was studied by differential scanning calorimetry (DSC), NMR, IR, and viscosity monitoring. The results suggested that the accelerating mechanism of CDI involves (1) acylation of DICY with CDI to give the corresponding adduct with enhanced solubility, (2) the consequent release of imidazole that can react with epoxide, and (3) abstraction of proton of DICY by the alkoxide moiety to give the corresponding DICY anion endowed with enhanced nucleophilicity.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: